Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Regulatory lawsuit

Arizona sues L'Oreal over hair relaxer cancer

Analysis based on 16 articles · First reported Sep 11, 2026 · Last updated Sep 14, 2026

Sentiment
-10
Attention
4
Articles
16
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The lawsuit adds to L Oréal's mounting legal exposure from over 12,000 consolidated hair relaxer claims, raising the prospect of significant penalties, damages, and potential product restrictions that could weigh on its consumer products segment. Broader cosmetics and personal care peers such as Revlon face similar litigation risk, though the direct near-term market impact is likely limited given the company's size and the lengthy litigation timeline.

cosmetics legal services consumer goods

United States — Arizona Attorney General Kris Mayes filed a lawsuit in state court late Thursday against L Oréal, alleging the cosmetics company concealed evidence that its hair relaxer products could cause cancer in women. United States — Arizona is the first state to sue over alleged cancer risks linked to hair relaxers. The suit accuses L Oréal of violating state consumer protection laws by marketing products used predominantly by African American women without warning of alleged ovarian and uterine cancer risks. United States — Arizona seeks penalties, damages, and a court order forcing L Oréal to stop selling the products unless it warns of the cancer risk. The lawsuit follows a 2022 United States — National Institutes of Health study that found women using the products several times a year were more than twice as likely to develop uterine cancer. L Oréal faces more than 12,000 similar lawsuits consolidated in a Chicago federal court as multidistrict litigation, with trials possibly beginning next year. Revlon and other makers are also named in related suits. L Oréal maintains its products undergo rigorous safety reviews and that the claims lack legal or scientific merit.

stock
L Oréal is the primary defendant, accused of concealing cancer risks from hair relaxer products and facing potential penalties, damages, and an injunction; the suit adds to over 12,000 consolidated claims that could pressure its legal liabilities and reputation.
Importance 100.0 Sentiment -35.0
loc
United States — Arizona is the plaintiff, becoming the first state to sue L Oréal over hair relaxer cancer risks, seeking penalties, damages, and a court order to halt sales absent cancer warnings.
Importance 85.0 Sentiment 0.0
per
United States — Arizona Attorney General Kris Mayes filed the lawsuit, driving the state's consumer protection action against L Oréal.
Importance 70.0 Sentiment 0.0
priv
Revlon is named alongside L Oréal in related hair relaxer lawsuits and has denied any connection between its products and cancer, exposing it to similar litigation risk.
Importance 30.0 Sentiment -15.0
govactor
The United States — National Institutes of Health published the 2022 study linking hair relaxer use to elevated uterine cancer risk, which triggered the wave of lawsuits against L Oréal and other makers.
Importance 25.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.